Insights

Robotics expansion Enovis is actively expanding into robotic-assisted surgery through the eCential Robotics acquisition, signaling a strategic opportunity to offer enabling technologies, integration services, and training programs that align with their robotics roadmap and orthopedics portfolio.

Enabling tech portfolio With a broad set of brands and technologies (DonJoy, Aircast, EMPOWR, MotionMD, SMR, Ligamys, DynaNail) and an emphasis on enabling technologies, there is a clear sales channel for complementary hardware, software, and disposable accessories that integrate across their product ecosystem.

Digital ops focus Adoption of Microsoft Power Apps, Salesforce, SAP Concur, and other modern tools indicates a push toward digital workflows and efficiency; opportunities exist to offer integrated software solutions, data analytics, and remote monitoring that enhance surgeon and clinician productivity.

Financial momentum Revenue is substantial within the mid-market range and the company is pursuing strategic acquisitions and stock activity signaling growth focus; this environment may favor multi-year procurement deals, phased technology implementations, and value-based selling around outcomes.

Global reach A large, worldwide workforce and a portfolio spanning multiple regions creates demand for scalable training, service contracts, and localized deployment support, presenting opportunities for service level agreements, maintenance, and regional implementation projects.

Similar companies to Enovis

Enovis Tech Stack

Enovis uses 8 technology products and services including Microsoft Power Apps, Salesforce Lightning, SAS, and more. Explore Enovis's tech stack below.

Media & News

Enovis's Email Address Formats

Enovis uses at least 3 email formats:
Enovis Email FormatsExamplePercentage
First.Last@enovis.comJohn.Doe@enovis.com
96%
First.Middle@enovis.comJohn.Michael@enovis.com
2%
Fir.Last@enovis.comJoh.Doe@enovis.com
2%

Frequently Asked Questions

What is Enovis's stock symbol?

Minus sign iconPlus sign icon
Enovis is a publicly traded company; the company's stock symbol is ENOV.

What is Enovis's official website and social media links?

Minus sign iconPlus sign icon
Enovis's official website is enovis.com and has social profiles on LinkedIn and Crunchbase.

How much revenue does Enovis generate?

Minus sign iconPlus sign icon
As of October 2026, Enovis's annual revenue is estimated to be $1B - $10B.

What is Enovis's NAICS code?

Minus sign iconPlus sign icon
Enovis's NAICS code is 62 - Health Care and Social Assistance.

How many employees does Enovis have currently?

Minus sign iconPlus sign icon
As of October 2026, Enovis has approximately 3.2K employees across 6 continents, including North America, Europe and Africa. Key team members include Chief Executive Officer: T. S., Cfo, Surgical Australia: P. B. and Chief Compliance Officer: D. E. Explore Enovis's employee directory with LeadIQ.

What industry does Enovis belong to?

Minus sign iconPlus sign icon
Enovis operates in the Hospitals and Health Care industry.

What technology does Enovis use?

Minus sign iconPlus sign icon
Enovis's tech stack includes Microsoft Power Apps, Salesforce Lightning, SAS, GitHub, CircleCI, Trello, SAP Concur and Atlassian Confluence.

What is Enovis's email format?

Minus sign iconPlus sign icon
Enovis's email format typically follows the pattern of First.Last@enovis.com. Find more Enovis email formats with LeadIQ.

How much funding has Enovis raised to date?

Minus sign iconPlus sign icon
As of October 2026, Enovis has raised $400M in funding. The last funding round occurred on Nov 20, 2023 for $400M.
Enovis logo

Enovis

Hospitals and Health CareDelaware, United States1001-5000 Employees

Enovis is a global medical technology company focused on developing clinically differentiated solutions that aim to improve patient outcomes and restore motion. The company emphasizes collaboration with health professionals to advance care that is smarter, more personalized, and more effective, while seeking to improve operational efficiency for surgeons and clinicians. Based in Wilmington, Delaware, United States, Enovis maintains a broad, multinational presence and pursues growth through innovation, strategic acquisitions, and continuous improvement.

Its offerings span a broad range of products and integrated technologies used in orthopedics and rehabilitation, supported by brands such as DonJoy and Aircast. The company serves hospitals, health systems, clinics, and other providers working to treat musculoskeletal conditions across reconstruction, prevention, and recovery, with a focus on improving patient outcomes and care pathways. A recent development includes the June 2026 launch of the Spinamic Hybrid Scoliosis Brace, which combines corrective performance with wearability for adolescents.

Section iconCompany Overview

Website
enovis.com
Stock Symbol
ENOV
NAICS Code
62 - Health Care and Social Assistance
Employees
1001-5000

Section iconFunding & Financials

  • $400M

    Enovis has raised a total of $400M of funding over 1 rounds. Their latest funding round was raised on Nov 20, 2023 in the amount of $400M as a Post IPO Debt.

  • $1B - $10B

    Enovis's revenue is estimated to be in the range of $1B - $10B

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.